NeurologyLive® published an earlier version of this article. Intravenous (IV) efgartigimod (Vyvgart; argenx) had a significant …
Tag:
generalized myasthenia gravis
-
-
The April 30 FDA Approval of Nipocamab-aahu (Imaavy; Johnson & Johnson) for generalized myasthenia gravis (gMG) …
-
Zilucoplan (Zilbrysq; UCB), a once-daily subcutaneous C5 complement inhibitor, continues to demonstrate sustained clinical value in …